Statins enhance the chemosensitivity of R-CHOP in diffuse large B-cell lymphoma

References

• Cheson BD, Pfistner B, Juweid ME, et al. Revised response criteria for malignant lymphoma. J Clin Oncol. 2007;25(5):579–586.
   PubMed Web of Science ®Google Scholar
• Coiffier B, Thieblemont C, Van Den Neste E, et al. Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the groupe d'Etudes des lymphomes de l'Adulte. Blood. 2010;116(12):2040–2045.
   PubMed Web of Science ®Google Scholar
• Habermann TM, Weller EA, Morrison VA, et al. Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma. J Clin Oncol. 2006;24(19):3121–3127.
   PubMed Web of Science ®Google Scholar
• Grundy SM, Stone NJ. 2018 American Heart Association/American College of Cardiology/Multisociety Guideline on the management of blood cholesterol-secondary prevention. JAMA Cardiol. 2019;4(6):589–591.
   PubMed Web of Science ®Google Scholar
• Tomlinson B, Chan P, Zhang Y, et al. Efficacy and safety of add on therapies in patients with hypercholesterolemia undergoing statin therapy. Expert Opin Pharmacother. 2020;21(17):2137–2151.
   PubMed Web of Science ®Google Scholar
• Medina MW, Krauss RM. The role of HMGCR alternative splicing in statin efficacy. Trends Cardiovasc Med. 2009;19(5):173–177.
   PubMed Web of Science ®Google Scholar
• Madison BB. Srebp2: a master regulator of sterol and fatty acid synthesis. J Lipid Res. 2016;57(3):333–335.
   PubMed Web of Science ®Google Scholar
• Preta G. New insights into targeting membrane lipids for cancer therapy. Front Cell Dev Biol. 2020;8:571237.
   PubMed Web of Science ®Google Scholar
• Couttenier A, Lacroix O, Vaes E, et al. Statin use is associated with improved survival in ovarian cancer: a retrospective population-based study. PLOS One. 2017;12(12):e0189233.
   PubMed Web of Science ®Google Scholar
• Gordon JA, Buonerba C, Pond G, et al. Statin use and survival in patients with metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide after docetaxel failure: the International Retrospective Observational STABEN Study. Oncotarget. 2018;9(28):19861–19873.
   PubMedGoogle Scholar
• Habis M, Wroblewski K, Bradaric M, et al. Statin therapy is associated with improved survival in patients with non-serous-papillary epithelial ovarian cancer: a retrospective cohort analysis. PLOS One. 2014;9(8):e104521.
   PubMed Web of Science ®Google Scholar
• Renman D, Lundberg E, Gunnarsson U, et al. Statin consumption as a risk factor for developing colorectal cancer: a retrospective case study. World J Surg Oncol. 2017;15(1):222.
   PubMed Web of Science ®Google Scholar
• Smyth L, Blunt DN, Gatov E, et al. Statin and cyclooxygenase-2 inhibitors improve survival in newly diagnosed diffuse large B-cell lymphoma: a large population-based study of 4913 subjects. Br J Haematol. 2020;191(3):396–404.
   PubMed Web of Science ®Google Scholar
• Cho SF, Yang YH, Liu YC, et al. Previous exposure to statin may reduce the risk of subsequent non-Hodgkin lymphoma: a nationwide population-based case-control study. PLOS One. 2015;10(10):e0139289.
   PubMed Web of Science ®Google Scholar
• Nowakowski GS, Maurer MJ, Habermann TM, et al. Statin use and prognosis in patients with diffuse large B-cell lymphoma and follicular lymphoma in the rituximab era. J Clin Oncol. 2010;28(3):412–417.
   PubMed Web of Science ®Google Scholar
• Chou R, Dana T, Blazina I, et al. Statins for prevention of cardiovascular disease in adults: evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2016;316(19):2008–2024.
   PubMed Web of Science ®Google Scholar
• Fong CW. Statins in therapy: understanding their hydrophilicity, lipophilicity, binding to 3-hydroxy-3-methylglutaryl-CoA reductase, ability to cross the blood brain barrier and metabolic stability based on electrostatic molecular orbital studies. Eur J Med Chem. 2014;85:661–674.
   PubMed Web of Science ®Google Scholar
• Coiffier B, Lepage E, Briere J, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med. 2002;346(4):235–242.
   PubMed Web of Science ®Google Scholar
• Hans CP, Weisenburger DD, Greiner TC, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004;103(1):275–282.
   PubMed Web of Science ®Google Scholar
• International Non-Hodgkin's lymphoma prognostic factors Project. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med. 1993;329:987–994.
   PubMed Web of Science ®Google Scholar
• Cheson BD, Fisher RI, Barrington SF, et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014;32(27):3059–3068.
   PubMed Web of Science ®Google Scholar
• Reis A, Rudnitskaya A, Blackburn GJ, et al. A comparison of five lipid extraction solvent systems for lipidomic studies of human LDL. J Lipid Res. 2013;54(7):1812–1824.
   PubMed Web of Science ®Google Scholar
• Amundson DM, Zhou M. Fluorometric method for the enzymatic determination of cholesterol. J Biochem Biophys Methods. 1999;38(1):43–52.
   PubMedGoogle Scholar
• Agarwal NK, Qu C, Kunkalla K, et al. Transcriptional regulation of serine/threonine protein kinase (AKT) genes by glioma-associated oncogene homolog 1. J Biol Chem. 2013;288(21):15390–15401.
   PubMed Web of Science ®Google Scholar
• Mohammad RM, Wall NR, Dutcher JA, et al. The addition of bryostatin 1 to cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy improves response in a CHOP-resistant human diffuse large cell lymphoma xenograft model. Clin Cancer Res. 2000;6:4950–4956.
   PubMed Web of Science ®Google Scholar
• Ennishi D, Asai H, Maeda Y, et al. Statin-independent prognosis of patients with diffuse large B-cell lymphoma receiving rituximab plus CHOP therapy. Ann Oncol. 2010;21(6):1217–1221.
   PubMed Web of Science ®Google Scholar
• Koo YX, Tan DS, Tan IB, et al. Effect of concomitant statin, metformin, or aspirin on rituximab treatment for diffuse large B-cell lymphoma. Leuk Lymphoma. 2011;52(8):1509–1516.
   PubMed Web of Science ®Google Scholar
• Samaras P, Heider H, Haile SR, et al. Concomitant statin use does not impair the clinical outcome of patients with diffuse large B cell lymphoma treated with rituximab-CHOP. Ann Hematol. 2010;89(8):783–787.
   PubMed Web of Science ®Google Scholar
• Desai P, Wallace R, Anderson ML, et al. An analysis of the effect of statins on the risk of non-Hodgkin's lymphoma in the women's health initiative cohort. Cancer Med. 2018;7(5):2121–2130.
   PubMed Web of Science ®Google Scholar
• Ye X, Zhang G, Righolt C, et al. Associations between statin use and risk of non-Hodgkin lymphomas by subtype. Int J Cancer. 2018;143(4):971–979.
   PubMed Web of Science ®Google Scholar
• Jacobs EJ, Newton CC, Thun MJ, et al. Long-term use of cholesterol-lowering drugs and cancer incidence in a large United States cohort. Cancer Res. 2011;71(5):1763–1771.
   PubMed Web of Science ®Google Scholar
• Lange Y, Swaisgood MH, Ramos BV, et al. Plasma membranes contain half the phospholipid and 90% of the cholesterol and sphingomyelin in cultured human fibroblasts. J Biol Chem. 1989;264(7):3786–3793.
   PubMed Web of Science ®Google Scholar
• Kawata S, Takaishi K, Nagase T, et al. Increase in the active form of 3-hydroxy-3-methylglutaryl coenzyme a reductase in human hepatocellular carcinoma: possible mechanism for alteration of cholesterol biosynthesis. Cancer Res. 1990;50(11):3270–3273.
   PubMed Web of Science ®Google Scholar
• Wang CY, Liu PY, Liao JK. Pleiotropic effects of statin therapy: molecular mechanisms and clinical results. Trends Mol Med. 2008;14(1):37–44.
   PubMed Web of Science ®Google Scholar
• Penkauskas T, Zentelyte A, Ganpule S, et al. Pleiotropic effects of statins via interaction with the lipid bilayer: a combined approach. Biochim Biophys Acta Biomembr. 2020;1862(9):183306.
   PubMed Web of Science ®Google Scholar
• Wang W, Collie-Duguid E, Cassidy J. Cerivastatin enhances the cytotoxicity of 5-fluorouracil on chemosensitive and resistant colorectal cancer cell lines. FEBS Lett. 2002;531(3):415–420.
   PubMed Web of Science ®Google Scholar
• Feleszko W, Mlynarczuk I, Balkowiec-Iskra EZ, et al. Lovastatin potentiates antitumor activity and attenuates cardiotoxicity of doxorubicin in three tumor models in mice. Clin Cancer Res. 2000;6(5):2044–2052.
   PubMed Web of Science ®Google Scholar
• Fromigue O, Hamidouche Z, Marie PJ. Statin-induced inhibition of 3-hydroxy-3-methyl glutaryl coenzyme a reductase sensitizes human osteosarcoma cells to anticancer drugs. J Pharmacol Exp Ther. 2008;325(2):595–600.
   PubMed Web of Science ®Google Scholar
• Jeong A, Suazo KF, Wood WG, et al. Isoprenoids and protein prenylation: implications in the pathogenesis and therapeutic intervention of Alzheimer's disease. Crit Rev Biochem Mol Biol. 2018;53(3):279–310.
   PubMed Web of Science ®Google Scholar
• Lee JS, Roberts A, Juarez D, et al. Statins enhance efficacy of venetoclax in blood cancers. Sci Transl Med. 2018;10:eaaq1240.
   PubMed Web of Science ®Google Scholar